Medical/Pharmaceuticals

Second NRF2 Degrader Enters Clinical Development: Nutshell Therapeutics' NTS231 Received FDA IND Clearance

SHANGHAI, Sept. 25, 2026 /PRNewswire/ -- Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, announced FDA IND clearance for NTS231, a covalent allosteric molecular glue degrader of NRF2, to launch cli...

2026-09-25 20:00 3713

Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters

* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...

2026-09-25 15:52 1509

Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam

HANOI, Vietnam, Sept. 25, 2026 /PRNewswire/ -- Greenfield Dental has recorded a significant surge in international patient volume with over 300% growth since 2025, reflecting Vietnam's emergence as a premier dental tourism destination and Greenfield's growing reputation.

2026-09-25 14:17 1220

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/...

2026-09-25 13:10 1261

XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain

* This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's AI and robotics-driven drug discovery platform and its transition to a clinical-stage organization. * Preclinical data demonstrate sub-nanomol...

2026-09-25 08:30 2778

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...

2026-09-25 01:44 1496

Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs

SHANGHAI and SHAOXING, China, Sept. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") and NovoCodex Biopharmaceuticals Co., Ltd. ("NovoCodex") jointlyannounced that the two companies have formally entered into a strategic collaboration agreement. The partnership will foc...

2026-09-24 22:00 3394

From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026

ZEISS Medical Technology advances its ZEISS Retina Workflow

2026-09-24 21:00 2052

Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology

WILMINGTON, Del., Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple therapeutic bispecific antibody programs ...

2026-09-24 19:00 1367

Carestream Healthcare International Launches STARVIEW Digital Radiography System

SHANGHAI, Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of theCARESTREAM STARVIEW Digital Radiography System, a focused, floor-mounted DR room designed for routine radiographic imaging. Healthcare facilities modernize radiography for different reasons, fr...

2026-09-24 14:07 1197

NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress

National Cancer Control Plans can and should include regionally appropriate guidelines according to abstracts presented by the National Comprehensive Cancer Network during global event hosted by the Union of International Cancer Control. PLYMOUTH MEETING, Pa. and HONG KONG, Sept. 24, 2026 /PRNew...

2026-09-24 08:03 1513

Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026

* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...

2026-09-24 08:00 1858

CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements

The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care ROCHESTER, N.Y., Sept. 23, 2026 /PRNewswire/ -- CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced six majo...

2026-09-23 22:15 2473

Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent

FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...

2026-09-23 20:00 1057

HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT

HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging cl...

2026-09-23 18:30 764

Leedon Technology Expands Healthcare Technical Capabilities with Authorised IMT Analytics Service Centre in Singapore

The new service centre builds on more than two decades of healthcare industry experience, expanding local calibration and technical support for medical gas flow devices and analysers SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Leedon Technology Pte Ltd, a Singapore-based healthcare solutions provi...

2026-09-23 18:17 1700

Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting

SAN FRANCISCO and SUZHOU, China, Sept. 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2026-09-23 16:48 1216

Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction

* Primary Endpoint Achieved in CBL-0202DD Phase 2 Trial—CBL-514 delivered statistically significant pain reduction across both FAS and PP populations compared with placebo. * Expansion Opportunity Beyond Dercum's Disease—Study findings support the potential development of CBL-514 for Lipedema...

2026-09-23 10:08 1148

Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis

ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...

2026-09-23 10:05 2039

GROWNSY Makes NANN Conference Debut, Partners with NANN and Pediatrician Dr. Molly O'Shea on NANNcast Episode Tackling Infant Nasal Congestion

The company exhibited for the first time at NANN's 42nd Annual Conference in West Palm Beach and will sponsor a NANNcast episode exploring why newborns are so vulnerable to nasal congestion — and what neonatal nurses and parents can do about it. NEW YORK, Sept. 22, 2026 /PRNewswire/ -- GROWNSY <...

2026-09-23 09:36 693
12345 ... 643

Week's Top Stories